US stock · US markets · public data

ALNY

Alnylam Pharmaceuticals Inc · Healthcare

Reference price$225.37Updated according to the public source
P/E38.01
P/B22.26
ROE96.56%
DY 12M0.00%
Net margin—
Net debt/equity—
Market capUS$ 30.2 B
Volume (shares)379,796
SectorHealthcare
Overview

About ALNY

Demonstrações públicas consolidadas + SEC Company Facts

Alnylam Pharmaceuticals Inc (ALNY) is a stock traded in US markets in the Healthcare sector. The consulted sources did not provide revenue, net income or operating cash flow for the latest reported periods.

Available statements: Income statement, Balance sheet, Cash flow. Most recent period in the first statement: 2026.

Distributions

Dividends and distributions · last 12 records

public data

The source returned no recent distributions for this asset.

SEC records describe reported fiscal periods, not ex-dividend or payment dates. Only separately reported quarters are shown; missing quarters do not mean zero dividends.

Financials

Income statement, balance sheet and cash flow

Available

Income statement

Account2023202420252026
Revenue$1,828,292,000.00$2,248,243,000.00$3,713,937,000.00—
Operating Income-$282,175,000.00-$176,885,000.00$501,578,000.00—
Net Income-$440,242,000.00-$278,157,000.00$313,747,000.00—
EPS Diluted-$3.52 / share-$2.18 / share$2.33 / share—

Balance sheet

Account2023202420252026
Total Assets$3,829,880,000.00$4,239,983,000.00$4,966,331,000.00—
Total Liabilities$4,050,524,000.00$4,172,895,000.00$4,177,155,000.00—
Total Equity-$220,644,000.00$67,088,000.00$789,176,000.00—
Shares Outstanding124,130,988 shares125,945,793 shares129,457,156 shares132,623,144 shares
Cash & Investments————

Cash flow

Account2023202420252026
Operating Cash Flow$104,156,000.00-$8,312,000.00$524,080,000.00—
Capital Expenditures$62,211,000.00$34,277,000.00$58,697,000.00—
Free Cash Flow$41,945,000.00-$42,589,000.00$465,383,000.00—
FAQ

Frequently asked questions

What is the price of ALNY?

The reference price available for ALNY is $225.37.

What is the P/E of ALNY?

The P/E ratio of ALNY is 38.01. This compares price with reported earnings per share; a non-positive multiple is not a low positive earnings multiple.

What is the P/B of ALNY?

The P/B of ALNY is 22.26. This compares price with reported book value per share.

What is the ROE of ALNY?

The ROE (Return on Equity) of ALNY is 96.56%. This relates the reported net result to shareholders' equity.

What is the dividend yield of ALNY?

The dividend yield of ALNY is 0.00%. The provider may use annualized dividends; this is not a guaranteed return.

What is the market cap of ALNY?

The market capitalization of ALNY is US$ 30.2 B.

What sector is ALNY in?

ALNY operates in the Healthcare sector.

FundamentalRadar · educational information, not investment advice.